Partners
CLEAR - Centre for Envelope Antibacterials partners with:
Denmark: With over 40,000 students and more than 9,000 employees, the University of Copenhagen is one of the largest institutions of research and education in the Nordic countries.
At the Department of Veterinary and animal sciences there are approximately 70 PhD students and research focuses on animal and zoonotic bacterial infections, with antimicrobial resistance and antimicrobial drug discovery being major research areas. As part of the Faculty of Health and Medical Science there is a close interaction between veterinary and human sciences giving strong support for One Health approaches.
The Spanish National Research Council (CSIC) is the largest public institution dedicated to research in Spain and the third largest in Europe. The CSIC has 70 fully own institutes and 53 additional Joint Research Units with universities or other research institutions, employing more than 13,000 people.
The Institute of Biomedicine of Valencia (IBV) is a fully own Institutes of CSIC with more than 150 members. Structural and bioinformatics studies on the cell signalling as well as the identification and characterization of new therapeutics targets for the rational development of novel drugs are major research lines at the IBV.
The Latvian Institute of Organic Synthesis (LIOS) is an independent research organization operating under the Ministry of Science and Education. It works in close collaboration with two major local universities to support student education both at undergraduate and graduate level.
LIOS is a working place for 300 employees, 110 of them holding a PhD degree. The main activities of LIOS are medicinal chemistry, pharmacology, process research and analytical chemistry.
Statens Serum Institut (SSI) employs more than 1400 people in the areas of research, surveillance of infectious diseases such as MRSA and TB, epidemiology and vaccinology. The Department of Microbiology and Infection Control, SSI has 140 employees primarily PhD's and MDs.
The department hosts the National Staphylococcus aureus Bacteremia (SAB) repository with all Danish SAB clinical isolates since 1958 (today more than 40,000 isolates) as well as all MRSA‟s since 1988 – in all 6,500 isolates.
The department is coordinator of the national surveillance of antimicrobial resistance through the work of DANMAP (Danish Study Group for Antimicrobial Resistance Surveillance), which is part of the European Antibiotic Resistance Surveillance program (EARS-net) considered to be one of the best surveillance programs in Europe.
Tübingen is among the world’s foremost universities and expressly supports common European values. These include the freedom of research and academia, the freedom of expression, the equality of all human beings and respect for human dignity, regardless of a person’s origins, religion, social status, gender, or sexual orientation. The University of Tübingen actively supports positive developments in society and peaceful coexistence, sustainable development, and the protection of the environment.
We regard the diversity of our students and employees as a great strength. It is our paramount task to support them in their quest for knowledge and education. An important factor in the success of a university is the motivation of its employees. With this in mind, the University makes every effort to enable its students and employees to reconcile the demands of family with their studies and working lives.
The University of Tübingen is committed to the highest standards of research and teaching across a broad spectrum of subjects.
- The University encourages interdisciplinary and international cooperation and upholds academic freedom in research and teaching, while acknowledging that the search for knowledge must be ethical.
- The University regards variety as essential to academic excellence and therefore supports equality between its members.
- It also provides further training in a variety of fields to equip its members with necessary non-academic skills.
The University of Amsterdam is ambitious, creative and committed: a leader in international science and a partner in innovation, the UvA has been inspiring generations since 1632.
Innovative and independent
We are an innovative, committed and independent university that is working towards a sustainable and prosperous future. Interdisciplinary research, cooperation and innovation are the key to scientific innovation. We rank among the international top institutions of higher education.Since 1632
Since its foundation in 1632, the UvA has grown into one of the leading universities across the full spectrum of the arts, humanities, natural sciences, social sciences and medical sciences. Its 6,000 staff, 3,000 PhD candidates and 40,000 students work and study together at various locations in Amsterdam.
This is how we look towards the future
Digitalisation in research is transforming the methods of all disciplines and the teaching of the future. For this reason, we invest in new areas of expertise, teamwork and a state-of-the-art infrastructure for research and new, innovative teaching methods. This leads to closer cooperation between disciplines – helped by our strength in artificial intelligence, data science and complexity – and to a smart combination of on-campus and online teaching, allowing for more interaction and a more intensive learning experience.
The UvA is a partner
Working with partners strengthens our teaching, research and impact. Together with the city, region and national and international partners, we seek an optimal interaction between science, practice and policy.
If you would like to know more about our ambitions, motives and challenges for the coming years, read our Strategic Plan or take a look at our Vision on Teaching and Learning.
We’re an award-winning institution with a history of independent thinking stretching back over 170 years. UCC is proud to be ranked in the top 1.1% of universities in the world. Our beautiful university opened its gates to just 115 students in 1849. We now have a student population of over 24,000.
University College Cork (UCC) is an internationally competitive, research-led university that plays a key role in the development of Ireland’s knowledge-based economy. Our institutional research strategy focuses on creating and supporting world-leading clusters of researchers, building on the research strengths of the University, and is aligned with key Government strategies including the Strategy for Higher Education to 2030 (Hunt Report), and Ireland’s Strategy for Research and Development, Science and Technology, Innovation 2020.
The UCC Research & Innovation Strategic Plan (2017-2022) details a number of performance targets for research and economic development that seek to position UCC and Ireland as an international innovation development hub.
In the strategic plan, UCC's key research priorities areas, based on areas in which UCC has excellence, scale, competitive advantage and network to deliver significant impact, were identified as:
- Culture, Society, Rights & Identities
- Financial & Business Services
- Food & Nutrition
- Future & Emerging Technologies
- Health & Wellbeing
- Sustainability & Climate Action
About Bioactive Coating
NAICONS is a company specializing in natural products, particularly molecules produced by microorganisms. It owns one of the world’s largest and most diversified collections of actinomycetes, filamentous bacteria that are prolific producers of bioactive molecules.
NAICONS team has extensive experience in natural products and bioinformatics and has developed the micro4all platform: an extensive and searchable database of molecules produced by its proprietary microorganisms, in ready-to-screen extracts and annotated through a proprietary automated pipeline. The database, which includes known and yet-to-be-described molecules, represents a gateway to natural molecules and will make the drug discovery process more effective and efficient, providing also ready access to hard-to-find microbial molecules.